Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT07239453
PHASE1
Clinical Trial of Comparing DA-2902 and DA-2902-R in Healthy Adult Subjects
Sponsor: Dong-A ST Co., Ltd.
View on ClinicalTrials.gov
Summary
This study is to compare pharmacokinetics and safety profiles of DA-2902 and DA-2902-R in healthy adult subjects
Official title: An Open-Label, Randomized, Single Oral Dose, Two-Sequence, Two-Period, CrossovSer Bioequivalence Study of "DA-2902" and "DA-2902-R" in Healthy Adults Under Fed Conditions
Key Details
Gender
All
Age Range
19 Years - 44 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-10-20
Completion Date
2025-12
Last Updated
2025-11-20
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
DA-2902
single dose administration (DA-2902 one tablet once a day)
DRUG
DA-2902-R
single dose administration (DA-2902-R one tablet once a day)
Locations (1)
CHA University Bundang Medical Center
Seongnam-si, Gyeonggi-do, South Korea